Drugs vs transplants in acute leukemias
Genetically modified T-cell therapy in multicenter trials
What has changed in AML treatment in the last 30 years?
Why it is important to involve children and adolescents in treatment decision-making
The role of proteasome inhibitors in multiple myeloma